Blurbs

Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spectrum Pharmaceuticals (SPPIResearch Report) and Tiziana Life Sciences (TLSAResearch Report) with bullish sentiments.

Spectrum Pharmaceuticals (SPPI)

JMP Securities analyst Reni Benjamin reiterated a Buy rating on Spectrum Pharmaceuticals today and set a price target of $4.00. The company’s shares closed last Wednesday at $0.68, close to its 52-week low of $0.60.

According to TipRanks.com, Benjamin has 0 stars on 0-5 stars ranking scale with an average return of -11.7% and a 30.3% success rate. Benjamin covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Iovance Biotherapeutics, and Allogene Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Spectrum Pharmaceuticals with a $5.67 average price target, a 756.5% upside from current levels. In a report issued on September 12, H.C. Wainwright also reiterated a Buy rating on the stock with a $12.00 price target.

See today’s best-performing stocks on TipRanks >>

Tiziana Life Sciences (TLSA)

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Tiziana Life Sciences today and set a price target of $3.00. The company’s shares closed last Wednesday at $0.76.

According to TipRanks.com, Mamtani has 0 stars on 0-5 stars ranking scale with an average return of -28.8% and a 20.3% success rate. Mamtani covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Lineage Cell Therapeutics, and Madrigal Pharmaceuticals.

Tiziana Life Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $3.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on SPPI:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More